Utility of Pediatric European Society for Blood and Marrow Transplantation Criteria as a Sensitive Tool for Identifying Pediatric Sinusoidal Obstruction Syndrome Associated With Nonrelapse Mortality: A Retrospective Single-Center Study.

IF 0.9 4区 医学 Q4 HEMATOLOGY
Teruki Sugiyama, Shunsuke Nakagawa, Shogo Horikawa, Jun Nagahama, Tatsuro Nakamura, Takanari Abematsu, Takuro Nishikawa, Yasuhiro Okamoto
{"title":"Utility of Pediatric European Society for Blood and Marrow Transplantation Criteria as a Sensitive Tool for Identifying Pediatric Sinusoidal Obstruction Syndrome Associated With Nonrelapse Mortality: A Retrospective Single-Center Study.","authors":"Teruki Sugiyama, Shunsuke Nakagawa, Shogo Horikawa, Jun Nagahama, Tatsuro Nakamura, Takanari Abematsu, Takuro Nishikawa, Yasuhiro Okamoto","doi":"10.1097/MPH.0000000000003278","DOIUrl":null,"url":null,"abstract":"<p><p>Sinusoidal obstruction syndrome (SOS) is a potentially fatal complication of hematopoietic stem cell transplantation (HSCT). Although SOS has traditionally been diagnosed using the Baltimore or modified Seattle criteria (conventional criteria), the European Society for Blood and Marrow Transplantation recently proposed diagnostic criteria for children (pEBMT). This study assessed how conventional and pEBMT criteria affect SOS incidence, severity, and outcomes. We retrospectively analyzed pediatric HSCT procedures conducted from 2007 to 2023. Out of 186 HSCT procedures, 36 met at least 1 SOS criterion. Of these, 30 met the pEBMT criteria, 16 met the conventional criteria, and 10 met both. Patients meeting either criterion had a significantly worse prognosis than those without SOS. All SOS cases with nonrelapse mortality (NRM) fulfilled the pEBMT criteria, and the cumulative incidence of NRM was higher in the pEBMT group than in the conventional group. Furthermore, even in all HSCT cases, the pEBMT criteria were associated with NRM and served as a risk factor. The finding that pEBMT may serve as a sensitive tool for predicting NRM is new and provides a noteworthy aspect of this study. Following the pEBMT criteria closely and initiating early treatment for SOS may help reduce NRM in affected patients.</p>","PeriodicalId":16693,"journal":{"name":"Journal of Pediatric Hematology/Oncology","volume":" ","pages":""},"PeriodicalIF":0.9000,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Hematology/Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MPH.0000000000003278","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Sinusoidal obstruction syndrome (SOS) is a potentially fatal complication of hematopoietic stem cell transplantation (HSCT). Although SOS has traditionally been diagnosed using the Baltimore or modified Seattle criteria (conventional criteria), the European Society for Blood and Marrow Transplantation recently proposed diagnostic criteria for children (pEBMT). This study assessed how conventional and pEBMT criteria affect SOS incidence, severity, and outcomes. We retrospectively analyzed pediatric HSCT procedures conducted from 2007 to 2023. Out of 186 HSCT procedures, 36 met at least 1 SOS criterion. Of these, 30 met the pEBMT criteria, 16 met the conventional criteria, and 10 met both. Patients meeting either criterion had a significantly worse prognosis than those without SOS. All SOS cases with nonrelapse mortality (NRM) fulfilled the pEBMT criteria, and the cumulative incidence of NRM was higher in the pEBMT group than in the conventional group. Furthermore, even in all HSCT cases, the pEBMT criteria were associated with NRM and served as a risk factor. The finding that pEBMT may serve as a sensitive tool for predicting NRM is new and provides a noteworthy aspect of this study. Following the pEBMT criteria closely and initiating early treatment for SOS may help reduce NRM in affected patients.

欧洲儿童血液和骨髓移植学会标准作为鉴别与非复发死亡率相关的儿童窦状窦阻塞综合征的敏感工具的应用:一项回顾性单中心研究。
窦状窦阻塞综合征(SOS)是造血干细胞移植(HSCT)的潜在致命并发症。虽然SOS传统上是使用巴尔的摩或修改的西雅图标准(传统标准)诊断的,但欧洲血液和骨髓移植协会最近提出了儿童诊断标准(pEBMT)。本研究评估了常规和pEBMT标准对SOS发生率、严重程度和预后的影响。我们回顾性分析了2007年至2023年进行的儿童HSCT手术。在186例HSCT手术中,36例符合至少1项SOS标准。其中,30人符合pEBMT标准,16人符合常规标准,10人两者都符合。符合任何一个标准的患者预后明显差于没有SOS的患者。所有SOS病例的非复发死亡率(NRM)均符合pEBMT标准,且pEBMT组NRM的累积发生率高于常规组。此外,即使在所有HSCT病例中,pEBMT标准也与NRM相关,并作为风险因素。pEBMT可能作为预测NRM的敏感工具的发现是新的,并且提供了本研究值得注意的一个方面。密切遵循pEBMT标准并对SOS进行早期治疗可能有助于减少受影响患者的NRM。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.90
自引率
8.30%
发文量
415
审稿时长
2.5 months
期刊介绍: ​Journal of Pediatric Hematology/Oncology (JPHO) reports on major advances in the diagnosis and treatment of cancer and blood diseases in children. The journal publishes original research, commentaries, historical insights, and clinical and laboratory observations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书